搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Arsenate reductase (arsC) CSB-YP302695YAQ
CSB-EP302695YAQ
CSB-BP302695YAQ
CSB-MP302695YAQ
CSB-EP302695YAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized lipoprotein MPN_152 (MPN_152), partial CSB-YP302696MLW
CSB-EP302696MLW
CSB-BP302696MLW
CSB-MP302696MLW
CSB-EP302696MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized protein MG061 homolog 1 (MPN_076), partial CSB-YP302697MLW
CSB-EP302697MLW
CSB-BP302697MLW
CSB-MP302697MLW
CSB-EP302697MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Protein MG054 homolog (MPN_067) CSB-YP302698MLW
CSB-EP302698MLW
CSB-BP302698MLW
CSB-MP302698MLW
CSB-EP302698MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized lipoprotein MG045 homolog (MPN_058) CSB-YP302699MLW
CSB-EP302699MLW
CSB-BP302699MLW
CSB-MP302699MLW
CSB-EP302699MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized lipoprotein MG040 homolog (MPN_052), partial CSB-YP302700MLW
CSB-EP302700MLW
CSB-BP302700MLW
CSB-MP302700MLW
CSB-EP302700MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Histidine--tRNA ligase (hisS) CSB-YP302701MLW
CSB-EP302701MLW
CSB-BP302701MLW
CSB-MP302701MLW
CSB-EP302701MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized protein MPN_037 (MPN_037) CSB-YP302702MLW
CSB-EP302702MLW
CSB-BP302702MLW
CSB-MP302702MLW
CSB-EP302702MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized protein MG028 homolog (MPN_031), partial CSB-YP302703MLW1
CSB-EP302703MLW1
CSB-BP302703MLW1
CSB-MP302703MLW1
CSB-EP302703MLW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Fructose-bisphosphate aldolase (fba) CSB-YP302704MLW
CSB-EP302704MLW
CSB-BP302704MLW
CSB-MP302704MLW
CSB-EP302704MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Bifunctional protein FolD (folD) CSB-YP302705MLW
CSB-EP302705MLW
CSB-BP302705MLW
CSB-MP302705MLW
CSB-EP302705MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized protein MPN_012 (MPN_012) CSB-YP302706MLW
CSB-EP302706MLW
CSB-BP302706MLW
CSB-MP302706MLW
CSB-EP302706MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Serine--tRNA ligase (serS) CSB-YP302707MLW
CSB-EP302707MLW
CSB-BP302707MLW
CSB-MP302707MLW
CSB-EP302707MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae DegV domain-containing protein MG450 homolog (MPN_664) CSB-YP302708MLW
CSB-EP302708MLW
CSB-BP302708MLW
CSB-MP302708MLW
CSB-EP302708MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized protein MG443 homolog (MPN_657), partial CSB-YP302709MLW1
CSB-EP302709MLW1
CSB-BP302709MLW1
CSB-MP302709MLW1
CSB-EP302709MLW1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized protein MPN_146 (MPN_146) CSB-YP302710MLW
CSB-EP302710MLW
CSB-BP302710MLW
CSB-MP302710MLW
CSB-EP302710MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized lipoprotein MPN_650 (MPN_650) CSB-YP302711MLW
CSB-EP302711MLW
CSB-BP302711MLW
CSB-MP302711MLW
CSB-EP302711MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized lipoprotein MG439 homolog 3 (MPN_644) CSB-YP302712MLW
CSB-EP302712MLW
CSB-BP302712MLW
CSB-MP302712MLW
CSB-EP302712MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uncharacterized lipoprotein MG439 homolog 6 (MPN_639) CSB-YP302713MLW
CSB-EP302713MLW
CSB-BP302713MLW
CSB-MP302713MLW
CSB-EP302713MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Mycoplasma pneumoniae Uridylate kinase (pyrH) CSB-YP302714MLW
CSB-EP302714MLW
CSB-BP302714MLW
CSB-MP302714MLW
CSB-EP302714MLW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>